Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

BrightGuard Covers NYC, Galderma Uncovers Rosacea Burden, Dermira's Qbrexza Approved

BrightGuard dispensers have now been installed at 53 public pools and 11 beaches in various locations throughout metropolitan New York. The impact of rosacea can be significant for affected patients. According to survey results released last month by Galderma, 86% of patients with rosacea modify their behavior in attempts to manage disease symptoms, and more than half say the disease has impacted their work productivity. The FDA has approved Qbrexza cloth (glycopyrronium) from Dermira for the topical treatment of primary axillary hyperhidrosis in patients 9 years of age and older.

Advertisement

In This Series

View More

Advertisement